A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 26, 2017
|
| In: |
Blood
Year: 2017, Jahrgang: 130, Heft: 5, Pages: 597-605 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2017-03-771220 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1182/blood-2017-03-771220
|
| Verfasserangaben: | Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580087809 | ||
| 003 | DE-627 | ||
| 005 | 20220814221244.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180815s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2017-03-771220 |2 doi | |
| 035 | |a (DE-627)1580087809 | ||
| 035 | |a (DE-576)510087809 | ||
| 035 | |a (DE-599)BSZ510087809 | ||
| 035 | |a (OCoLC)1341017088 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sanchorawala, Vaishali |e VerfasserIn |0 (DE-588)1164558838 |0 (DE-627)1028976593 |0 (DE-576)510087876 |4 aut | |
| 245 | 1 | 2 | |a A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |c Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| 264 | 1 | |c May 26, 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Prepublished online as Blood First Edition paper, 26 May 2017 | ||
| 500 | |a Gesehen am 15.08.2018 | ||
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 130(2017), 5, Seite 597-605 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| 773 | 1 | 8 | |g volume:130 |g year:2017 |g number:5 |g pages:597-605 |g extent:9 |a A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2017-03-771220 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180815 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |e 910000PS122405226 |e 910100PS122405226 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 999 | |a KXP-PPN1580087809 |e 3022427166 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Sanchorawala","display":"Sanchorawala, Vaishali","role":"aut","given":"Vaishali"},{"family":"Schönland","display":"Schönland, Stefan","role":"aut","given":"Stefan"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis","title":"A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis"}],"origin":[{"dateIssuedDisp":"May 26, 2017","dateIssuedKey":"2017"}],"note":["Prepublished online as Blood First Edition paper, 26 May 2017","Gesehen am 15.08.2018"],"id":{"doi":["10.1182/blood-2017-03-771220"],"eki":["1580087809"]},"relHost":[{"part":{"issue":"5","text":"130(2017), 5, Seite 597-605","pages":"597-605","year":"2017","volume":"130","extent":"9"},"titleAlt":[{"title":"Blood online"}],"language":["eng"],"corporate":[{"display":"American Society of Hematology","role":"isb"}],"id":{"eki":["266886647"],"issn":["1528-0020"],"zdb":["1468538-3"]},"recId":"266886647","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosisBlood","pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-"}],"title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}]}],"recId":"1580087809","physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini"]}} | ||
| SRT | |a SANCHORAWAPHASE12STU2620 | ||